A detailed history of Two Sigma Investments, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Two Sigma Investments, LP holds 715,149 shares of TEVA stock, worth $12.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
715,149
Previous 137,600 419.73%
Holding current value
$12.2 Million
Previous $2.24 Million 476.3%
% of portfolio
0.03%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $9.13 Million - $11 Million
577,549 Added 419.73%
715,149 $12.9 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $49,215 - $67,007
3,851 Added 2.88%
137,600 $2.24 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $191,537 - $259,032
-17,951 Reduced 11.83%
133,749 $1.89 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $10,312 - $13,500
-1,270 Reduced 0.83%
151,700 $1.58 Million
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $4.41 Million - $6.31 Million
-589,823 Reduced 79.41%
152,970 $1.56 Million
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $2.92 Million - $3.85 Million
-406,156 Reduced 35.35%
742,793 $5.59 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $36.9 Million - $50.2 Million
-4,412,717 Reduced 79.34%
1,148,949 $10.2 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $2.21 Million - $2.64 Million
278,165 Added 5.26%
5,561,666 $50.7 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $31.7 Million - $55.3 Million
4,627,252 Added 705.11%
5,283,501 $42.6 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $1.03 Million - $1.45 Million
139,200 Added 26.92%
656,249 $4.94 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $3.39 Million - $4.35 Million
-463,147 Reduced 47.25%
517,049 $4.86 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $2.23 Million - $2.88 Million
282,576 Added 40.51%
980,196 $7.85 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $5.76 Million - $6.99 Million
686,986 Added 6460.28%
697,620 $6.8 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $105,276 - $122,929
10,634 New
10,634 $105,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $818,363 - $1.05 Million
-95,048 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $6.18 Million - $9.16 Million
-721,451 Reduced 88.36%
95,048 $856,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $6.97 Million - $11.3 Million
-858,680 Reduced 51.26%
816,499 $10.1 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $9.89 Million - $19.9 Million
-1,477,722 Reduced 46.87%
1,675,179 $15 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $15.6 Million - $25.6 Million
2,389,053 Added 312.77%
3,152,901 $30.9 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $4.64 Million - $7.23 Million
752,948 Added 6907.78%
763,848 $5.26 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $24.6 Million - $47.6 Million
-3,030,927 Reduced 99.64%
10,900 $101,000
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $47.4 Million - $60.9 Million
3,041,827 New
3,041,827 $47.7 Million
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $5.43 Million - $8.87 Million
-371,883 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $33.4 Million - $40.7 Million
-1,587,975 Reduced 81.03%
371,883 $8.01 Million
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $29.6 Million - $43.6 Million
1,763,766 Added 899.46%
1,959,858 $47.7 Million
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $18.5 Million - $24.4 Million
-1,107,214 Reduced 84.95%
196,092 $3.35 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $13.5 Million - $23 Million
1,204,574 Added 1220.04%
1,303,306 $24.7 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $1.52 Million - $3.18 Million
98,732
98,732 $1.74 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.